En la edición 45 de la instancia nacional del Concurso Premio Anual de la Salud, del Ministerio de Salud Pública de Cuba, fueron reconocidos varios trabajos realizados por investigadores miembros de la Sociedad Cubana de Inmunología. Ellos fueron: Leer más…
– Potent immunomodulatory and antitumor effect of anti-CD20-IL2no-alpha tri-functional immunocytokine for cancer therapy. Front Immunol. 2022 Dec 9;13:1021828.
– Action Mechanisms and Scientific Rationale of Using Nasal Vaccine (HeberNasvac) for the Treatment of Chronic Hepatitis B. Vaccines (Basel). 2022 Dec 7;10(12):2087.
– Neoadjuvant Trastuzumab and Pertuzumab in Combination with Standard Chemotherapy for HER2-Positive Early Breast Cancer: Real-World Practice in Cuba. Cancer Treat Res Commun. 2022 Dec 13;34:100670.
– Human B-1 cells are important contributors to the naturally-occurring IgM pool against the tumor-associated ganglioside Neu5GcGM3. Front Immunol. 2022 Nov 30;13:1061651.
– Anticuerpos antitransglutaminasa tisular en pacientes con síntomas gastrointestinales. Revista Cubana de Medicina, 2022;61(4).
– Nonspecific Effects of Infant Vaccines Make Children More Resistant to SARS-CoV-2 Infection. Children (Basel). 2022 Nov 29;9(12):1858.
– Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children. Int J Infect Dis. 2023 Jan;126:164-173. Leer más…
En la sección: Autoinmunidad, Autores cubanos en revistas extranjeras, COVID-19, Infectología, Inflamación, Inmunidad tumoral, Vacunología. Publicado en: .
– COVID-19 and blood cancer in the vaccination era
– A Covid-19 Milestone Attained — A Correlate of Protection for Vaccines
– Efficacy and safety of COVID-19 vaccines
– Urgent Need for Next-Generation COVID-19 Vaccines
– SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression
En la sección: Artículos de revisión, COVID-19, Infectología, Presentación antigénica, Vacunología. Publicado en: .
– Increased IL-26 associates with markers of hyperinflammation and tissue damage in patients with acute COVID-19. Front. Immunol., 17 November 2022; https://doi.org/10.3389/fimmu.2022.1016991
– Deep learning reveals predictive sequence concepts within immune repertoires to immunotherapy. Science Advances, 2022;8(37). Leer más…
En la sección: COVID-19, Inmunidad tumoral, Inmunoterapia, Linfocitos T, Vacunología. Publicado en: .
– Saavedra D, Añé-Kourí AL, Llanez EM, Mena J, Lorenzo-Luaces P, Diaz H, et al. Immune, inflammatory and prothrombotic parameters in COVID-19 patients treated with an anti EGFR antibody. Immunol Lett. 2022 Sep 26;S0165-2478(22)00130-4.
– Oliver L, Alvarez R, Diaz R, Valdés A, Colligan SH, Nemeth MJ, et al. Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator. J Immunother Cancer. 2022 Sep;10(9):e004710.
– Más-Bermejo PI, Dickinson-Meneses FO, Almenares-Rodríguez K, Sánchez-Valdés L, Guinovart-Díaz R, Vidal-Ledo M, et al. Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study. Lancet Reg Health Am. 2022 Dec;16:100366.
En la sección: COVID-19, Infectología, Inflamación, Vacunología. Publicado en: .
– Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection. N Engl J Med 2022; 387:1333-1336.
– SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry. Nature, 2022; https://doi.org/10.1038/s41586-022-05282-z
– Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection. Nat Med, 2022; https://doi.org/10.1038/s41591-022-02078-6
En la sección: Autoinmunidad, COVID-19, Infectología, Inmunidad de mucosas, Vacunología. Publicado en: .